Recent progresses of exosome–liposome fusions in drug delivery

[1]  Y. Sasaki,et al.  Development and single‐particle analysis of hybrid extracellular vesicles fused with liposomes using viral fusogenic proteins , 2022, FEBS open bio.

[2]  Ke Gong,et al.  Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer , 2022, Journal of Nanobiotechnology.

[3]  Hongbo Zhang,et al.  Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy , 2022, Science advances.

[4]  Chunzhen Yang,et al.  Tumor microenvironment-responsive MnSiO3-Pt@BSA-Ce6 nanoplatform for synergistic catalysis-enhanced sonodynamic and chemodynamic cancer therapy , 2022, Chinese Chemical Letters.

[5]  Lei Wu,et al.  Milk-derived exosomes exhibit versatile effects for improved oral drug delivery , 2021, Acta pharmaceutica Sinica. B.

[6]  He Zhang,et al.  Near-infrared light (NIR)-responsive nanoliposomes combining photodynamic therapy and chemotherapy for breast tumor control , 2021, Chinese Chemical Letters.

[7]  Jifeng Yu,et al.  Targeting CD47 for cancer immunotherapy , 2021, Journal of Hematology & Oncology.

[8]  Zhiqiang Yu,et al.  Integrating of lipophilic platinum(IV) prodrug into liposomes for cancer therapy on patient-derived xenograft model , 2021, Chinese Chemical Letters.

[9]  Dayong Yang,et al.  Construction and applications of DNA-based nanomaterials in cancer therapy , 2021, Chinese Chemical Letters.

[10]  Wei He,et al.  Liposome-based delivery of biological drugs , 2021, Chinese Chemical Letters.

[11]  Wenqing Li,et al.  Inhibiting collagen I production and tumor cell colonization in the lung via miR-29a-3p loading of exosome-/liposome-based nanovesicles , 2021, Acta pharmaceutica Sinica. B.

[12]  M. J. Wood,et al.  Extracellular vesicles as a next-generation drug delivery platform , 2021, Nature Nanotechnology.

[13]  Shaobo Ruan,et al.  Extracellular Vesicles as an Advanced Delivery Biomaterial for Precision Cancer Immunotherapy , 2021, Advanced healthcare materials.

[14]  B. Leavitt,et al.  The current landscape of nucleic acid therapeutics , 2021, Nature Nanotechnology.

[15]  G. Jenkins,et al.  COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts , 2021, Immunological reviews.

[16]  H. Kessler,et al.  RGD-Binding Integrins Revisited: How Recently Discovered Functions and Novel Synthetic Ligands (Re-)Shape an Ever-Evolving Field , 2021, Cancers.

[17]  F. Gao,et al.  Clodronate-loaded liposomal and fibroblast-derived exosomal hybrid system for enhanced drug delivery to pulmonary fibrosis. , 2021, Biomaterials.

[18]  Yi Wang.  Liposome as a delivery system for the treatment of biofilm‐mediated infections , 2021, Journal of applied microbiology.

[19]  M. Soukhtanloo,et al.  A review on liposome-based therapeutic approaches against malignant melanoma. , 2021, International journal of pharmaceutics.

[20]  Jiacan Su,et al.  Exosome-guided bone targeted delivery of Antagomir-188 as an anabolic therapy for bone loss , 2021, Bioactive materials.

[21]  Li Duan,et al.  Engineering exosomes for targeted drug delivery , 2021, Theranostics.

[22]  Jonghoon Choi,et al.  Exosome-based photoacoustic imaging guided photodynamic and immunotherapy for the treatment of pancreatic cancer. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[23]  Meiwan Chen,et al.  Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition , 2020 .

[24]  Okhil K. Nag,et al.  Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery , 2020, Molecules.

[25]  Marzieh Ebrahimi,et al.  Tumor extracellular vesicles loaded with exogenous Let-7i and miR-142 can modulate both immune response and tumor microenvironment to initiate a powerful anti-tumor response. , 2020, Cancer letters.

[26]  L. Qin,et al.  Isolation and characterization of exosomes for cancer research , 2020, Journal of Hematology & Oncology.

[27]  Haifeng Sun,et al.  Co-delivery of anticancer drugs and cell penetrating peptides for improved cancer therapy , 2020 .

[28]  Yuanyu Huang,et al.  Recent advances in photothermal and RNA interfering synergistic therapy , 2020 .

[29]  S. Shin,et al.  Engineering Smart Targeting Nanovesicles and Their Combination with Hydrogels for Controlled Drug Delivery , 2020, Pharmaceutics.

[30]  S. Sim,et al.  SERS-based Nanoplasmonic Exosome Analysis: Enabling Liquid Biopsy for Cancer Diagnosis and Monitoring Progression , 2020, BioChip Journal.

[31]  Y. Tao,et al.  Exosomes: key players in cancer and potential therapeutic strategy , 2020, Signal Transduction and Targeted Therapy.

[32]  Li Duan,et al.  Chondrocyte-Targeted MicroRNA Delivery by Engineered Exosomes toward a Cell-Free Osteoarthritis Therapy. , 2020, ACS applied materials & interfaces.

[33]  Dheeraj,et al.  Surface functionalization of exosomes for target-specific delivery and in vivo imaging & tracking: Strategies and significance. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[34]  P. Sun,et al.  Circumvent PEGylation dilemma by implementing matrix metalloproteinase-responsive chemistry for promoted tumor gene therapy , 2020 .

[35]  Zicai Liang,et al.  Efficient hepatic delivery and protein expression enabled by optimized mRNA and ionizable lipid nanoparticle , 2020, Bioactive Materials.

[36]  Zuobing Xiao,et al.  Cationic and temperature-sensitive liposomes loaded with eugenol for the application to silk , 2020 .

[37]  K. Bryniarski,et al.  Perspectives in Manipulating EVs for Therapeutic Applications: Focus on Cancer Treatment , 2020, International journal of molecular sciences.

[38]  J. Heyes,et al.  Lipid nanoparticles for nucleic acid delivery: Current perspectives. , 2020, Advanced drug delivery reviews.

[39]  Jianhong Yang,et al.  Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity. , 2020, Cellular immunology.

[40]  Michiko Kodama,et al.  Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer. , 2020, Biochemical and biophysical research communications.

[41]  Guping Tang,et al.  A supramolecular co-delivery strategy for combined breast cancer treatment and metastasis prevention , 2020 .

[42]  T. Schumacher,et al.  The CD47-SIRPα Immune Checkpoint. , 2020, Immunity.

[43]  M. Lord,et al.  Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy , 2020, Acta Pharmacologica Sinica.

[44]  Chun-Chieh Huang,et al.  Functionally Engineered Extracellular Vesicles Improve Bone Regeneration. , 2020, Acta biomaterialia.

[45]  Kecheng Zhang,et al.  Nucleic acid-based drug delivery strategies. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[46]  Xiaolong Liu,et al.  Equipping Natural Killer Cells with Specific Targeting and Checkpoint Blocking for Enhanced Adoptive Immunotherapy in Solid Tumors. , 2020, Angewandte Chemie.

[47]  A. Tamayol,et al.  Growth-Inhibitory Effect of Chitosan-Coated Liposomes Encapsulating Curcumin on MCF-7 Breast Cancer Cells , 2020, Marine drugs.

[48]  K. Cheng,et al.  Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs , 2020, Theranostics.

[49]  Raghu Kalluri,et al.  The biology, function, and biomedical applications of exosomes , 2020, Science.

[50]  I. Kocherova,et al.  Inclusion Biogenesis, Methods of Isolation and Clinical Application of Human Cellular Exosomes , 2020, Journal of clinical medicine.

[51]  L. Buscail,et al.  Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer , 2020, Nature Reviews Gastroenterology & Hepatology.

[52]  Tian Tian,et al.  Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer , 2020, Journal of Nanobiotechnology.

[53]  Guodong Yang,et al.  Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium , 2020, Theranostics.

[54]  D. Pang,et al.  Molecularly Engineered Macrophage-Derived Exosomes with Inflammation Tropism and Intrinsic Biosynthesis for Atherosclerosis Treatment. , 2019, Angewandte Chemie.

[55]  Hai‐Yan Xie,et al.  Responsive exosome nano-bioconjugates for synergistic cancer therapy. , 2019, Angewandte Chemie.

[56]  A. Gaharwar,et al.  Engineered Extracellular Vesicles with Synthetic Lipids via Membrane Fusion to Establish Efficient Gene Delivery. , 2019, International journal of pharmaceutics.

[57]  Weilei Hu,et al.  Cocktail Strategy Based on NK Cell-Derived Exosomes and Their Biomimetic Nanoparticles for Dual Tumor Therapy , 2019, Cancers.

[58]  Shi Hu,et al.  CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity , 2019, Nature Communications.

[59]  D. Maloney,et al.  HIGH RATE OF DURABLE COMPLETE REMISSION IN FOLLICULAR LYMPHOMA AFTER CD19 CAR‐T CELL IMMUNOTHERAPY , 2019, Blood.

[60]  R. Marasini,et al.  Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery. , 2019, Acta biomaterialia.

[61]  K. Veselkov,et al.  Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research , 2019, Gastroenterology research and practice.

[62]  S. Lockwood,et al.  Ovarian Cancer: An Integrated Review. , 2019, Seminars in oncology nursing.

[63]  C. Théry,et al.  Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication , 2019, Nature Cell Biology.

[64]  Kendall R. Sanson,et al.  Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities , 2018, Nature Communications.

[65]  B. Liu,et al.  Multifunctional Liposome: A Bright AIEgen-Lipid Conjugate with Strong Photosensitization. , 2018, Angewandte Chemie.

[66]  Keren Gu,et al.  Nanoliposomes as Vehicles for Astaxanthin: Characterization, In Vitro Release Evaluation and Structure , 2018, Molecules.

[67]  T. Andresen,et al.  Theranostic Imaging May Vaccinate against the Therapeutic Benefit of Long Circulating PEGylated Liposomes and Change Cargo Pharmacokinetics. , 2018, ACS nano.

[68]  K. Garber.  Alnylam launches era of RNAi drugs , 2018, Nature Biotechnology.

[69]  J. Soares,et al.  Intravenous infusion of xenon-containing liposomes generates rapid antidepressant-like effects , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[70]  S. Evans,et al.  Liposomal Delivery of Demineralized Dentin Matrix for Dental Tissue Regeneration , 2018, Tissue engineering. Part A.

[71]  Mengsu Yang,et al.  Efficient RNA drug delivery using red blood cell extracellular vesicles , 2018, Nature Communications.

[72]  H. Moulton,et al.  Anchor peptide captures, targets, and loads exosomes of diverse origins for diagnostics and therapy , 2018, Science Translational Medicine.

[73]  Y. Zhang,et al.  Exosomes Secreted by Adipose-Derived Stem Cells Contribute to Angiogenesis of Brain Microvascular Endothelial Cells Following Oxygen–Glucose Deprivation In Vitro Through MicroRNA-181b/TRPM7 Axis , 2018, Journal of Molecular Neuroscience.

[74]  Omkar U. Kawalekar,et al.  CAR T cell immunotherapy for human cancer , 2018, Science.

[75]  Juan Li,et al.  Recent Advances of Membrane-Cloaked Nanoplatforms for Biomedical Applications. , 2018, Bioconjugate chemistry.

[76]  R. Schekman,et al.  Extracellular Vesicles and Cancer: Caveat Lector , 2018 .

[77]  A. Veillette,et al.  SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy. , 2018, Trends in immunology.

[78]  H. Yin,et al.  Serum exosomes can restore cellular function in vitro and be used for diagnosis in dysferlinopathy , 2018, Theranostics.

[79]  Hakho Lee,et al.  New Technologies for Analysis of Extracellular Vesicles. , 2018, Chemical reviews.

[80]  D. Rockey,et al.  Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice , 2018, Gastroenterology.

[81]  Saheli Samanta,et al.  Exosomes: new molecular targets of diseases , 2017, Acta Pharmacologica Sinica.

[82]  Massimo Aria,et al.  bibliometrix: An R-tool for comprehensive science mapping analysis , 2017, J. Informetrics.

[83]  A. Agostiano,et al.  Liposome-modified titanium surface: A strategy to locally deliver bioactive molecules. , 2017, Colloids and surfaces. B, Biointerfaces.

[84]  Alexander V Kabanov,et al.  Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain. , 2017, Biomaterials.

[85]  R. S. Conlan,et al.  Exosomes as Reconfigurable Therapeutic Systems. , 2017, Trends in molecular medicine.

[86]  R. Brekken,et al.  Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies , 2017, British Journal of Cancer.

[87]  G. Vassalli,et al.  Exosomes: Therapy delivery tools and biomarkers of diseases , 2017, Pharmacology & therapeutics.

[88]  Raghu Kalluri,et al.  Exosomes Facilitate Therapeutic Targeting of Oncogenic Kras in Pancreatic Cancer , 2017, Nature.

[89]  D. Prockop,et al.  Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus , 2017, Proceedings of the National Academy of Sciences.

[90]  Xuesi Chen,et al.  Anti-tumor effects of combined doxorubicin and siRNA for pulmonary delivery , 2017 .

[91]  Stefania Raimondo,et al.  Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth , 2017, Theranostics.

[92]  Wei Liu,et al.  Microfluidic Electroporation-Facilitated Synthesis of Erythrocyte Membrane-Coated Magnetic Nanoparticles for Enhanced Imaging-Guided Cancer Therapy. , 2017, ACS nano.

[93]  Y. Takakura,et al.  Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA. , 2016, Biomaterials.

[94]  Anastasia Khvorova,et al.  Exosome-mediated Delivery of Hydrophobically Modified siRNA for Huntingtin mRNA Silencing. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[95]  I. Vattulainen,et al.  Role of charged lipids in membrane structures - Insight given by simulations. , 2016, Biochimica et biophysica acta.

[96]  Joshua L Hood.  Post isolation modification of exosomes for nanomedicine applications. , 2016, Nanomedicine.

[97]  Robert J. Lee,et al.  The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery. , 2016, Advanced drug delivery reviews.

[98]  Katharina Landfester,et al.  Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. , 2016, Nature nanotechnology.

[99]  Clotilde Théry,et al.  Communication by Extracellular Vesicles: Where We Are and Where We Need to Go , 2016, Cell.

[100]  R. Schiffelers,et al.  PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[101]  Yoshihiro Sasaki,et al.  Engineering hybrid exosomes by membrane fusion with liposomes , 2016, Scientific Reports.

[102]  J. Helms,et al.  Rescuing failed oral implants via Wnt activation. , 2016, Journal of clinical periodontology.

[103]  Gary K. Schwartz,et al.  Tumour exosome integrins determine organotropic metastasis , 2015, Nature.

[104]  G. Warnock,et al.  Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy , 2015, Oncotarget.

[105]  Jaesung Park,et al.  Generation of nanovesicles with sliced cellular membrane fragments for exogenous material delivery. , 2015, Biomaterials.

[106]  Richa Gupta,et al.  Exosomes as drug delivery vehicles for Parkinson's disease therapy. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[107]  Molly M Stevens,et al.  Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[108]  Zhiping Zhang,et al.  Cell or Cell Membrane-Based Drug Delivery Systems , 2015, Theranostics.

[109]  Hakho Lee,et al.  Acoustic purification of extracellular microvesicles. , 2015, ACS nano.

[110]  Tianzhi Yang,et al.  Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio , 2015, Pharmaceutical Research.

[111]  B. Denecke,et al.  Exosomes as a Nanodelivery System: a Key to the Future of Neuromedicine? , 2014, Molecular Neurobiology.

[112]  A. Akinc,et al.  Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and Efficacy , 2014, Molecular therapy. Nucleic acids.

[113]  Thomas J. Anchordoquy,et al.  Surface Functionalization of Exosomes Using Click Chemistry , 2014, Bioconjugate chemistry.

[114]  Mark Ibberson,et al.  Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells. , 2014, Cell reports.

[115]  A. Elkahloun,et al.  CD47-dependent immunomodulatory and angiogenic activities of extracellular vesicles produced by T cells , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[116]  B. Yu,et al.  Exosomes Derived from Mesenchymal Stem Cells , 2014, International journal of molecular sciences.

[117]  Jian Song,et al.  A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.

[118]  Jaesung Park,et al.  Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. , 2013, ACS nano.

[119]  H. Gendelman,et al.  Specific Transfection of Inflamed Brain by Macrophages: A New Therapeutic Strategy for Neurodegenerative Diseases , 2013, PloS one.

[120]  Lynne T. Bemis,et al.  Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.

[121]  M. Zöller,et al.  Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. , 2012, The international journal of biochemistry & cell biology.

[122]  Per Sunnerhagen,et al.  Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes , 2012, Nucleic acids research.

[123]  I. Weissman,et al.  The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications. , 2012, Current opinion in immunology.

[124]  C. Shemesh,et al.  Near-Infrared Image-Guided Delivery and Controlled Release Using Optimized Thermosensitive Liposomes , 2012, Pharmaceutical Research.

[125]  Leaf Huang,et al.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. , 2012, Vaccine.

[126]  J. Le Pecq,et al.  Increasing vaccine potency through exosome antigen targeting. , 2011, Vaccine.

[127]  Christoph Peters,et al.  Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment. , 2011, Nature nanotechnology.

[128]  Ronnie H. Fang,et al.  Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.

[129]  O. Atrooz.  Efects of Alkylresorcinolic Lipids Obtained from Acetonic Extract of Jordanian Wheat Grains on Liposome Properties , 2011 .

[130]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[131]  L. Eisenlohr,et al.  Exosome-Driven Antigen Transfer for MHC Class II Presentation Facilitated by the Receptor Binding Activity of Influenza Hemagglutinin , 2010, The Journal of Immunology.

[132]  Dongmei Sun,et al.  A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[133]  G. Freeman,et al.  TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity , 2010, Immunological reviews.

[134]  Michael F. Flessner,et al.  Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence , 2010, Nature Reviews Clinical Oncology.

[135]  Elaine C. Campbell,et al.  Novel MHC Class I Structures on Exosomes1 , 2009, The Journal of Immunology.

[136]  I. Santamaría-Holek,et al.  Thermodynamics and dynamics of the formation of spherical lipid vesicles , 2009, Journal of biological physics.

[137]  K. Higaki,et al.  Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers. , 2008, International journal of pharmaceutics.

[138]  R. Prassl,et al.  Inhalable liposomal formulation for vasoactive intestinal peptide. , 2008, International journal of pharmaceutics.

[139]  Kathryn L. Schornberg,et al.  Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme , 2008 .

[140]  N. Hogg,et al.  CD8+ Dendritic Cells Use LFA-1 to Capture MHC-Peptide Complexes from Exosomes In Vivo1 , 2007, The Journal of Immunology.

[141]  R. Barrangou,et al.  CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes , 2007, Science.

[142]  J. Heyes,et al.  Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[143]  Wolfgang Meier,et al.  Block copolymer vesicles—using concepts from polymer chemistry to mimic biomembranes , 2005 .

[144]  Simon C Watkins,et al.  Exosomes Derived from IL-10-Treated Dendritic Cells Can Suppress Inflammation and Collagen-Induced Arthritis 1 , 2005, The Journal of Immunology.

[145]  Enhong Cao,et al.  Effect of freezing and thawing rates on denaturation of proteins in aqueous solutions. , 2003, Biotechnology and bioengineering.

[146]  Laurence Zitvogel,et al.  Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.

[147]  P. Ricciardi-Castagnoli,et al.  Proteomic Analysis of Dendritic Cell-Derived Exosomes: A Secreted Subcellular Compartment Distinct from Apoptotic Vesicles1 , 2001, The Journal of Immunology.

[148]  H. Geuze,et al.  Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. , 2000, Journal of cell science.

[149]  H. Brühl,et al.  Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection , 2000, Nature Medicine.

[150]  G. Blissard,et al.  Baculovirus gp64 envelope glycoprotein is sufficient to mediate pH-dependent membrane fusion , 1992, Journal of virology.

[151]  B. Pan,et al.  Loss of the transferrin receptor during the maturation of sheep reticulocytes in vitro. An immunological approach. , 1983, The Biochemical journal.

[152]  Song Fan,et al.  Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. , 2018, Biomaterials.

[153]  F. Wandosell,et al.  ImmunoPEGliposome-mediated reduction of blood and brain amyloid levels in a mouse model of Alzheimer's disease is restricted to aged animals. , 2017, Biomaterials.

[154]  Antonio P. Costa,et al.  Freeze-Anneal-Thaw Cycling of Unilamellar Liposomes: Effect on Encapsulation Efficiency , 2013, Pharmaceutical Research.